🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

ELMED Life Sciences raises $2.7 Mn in Series A from NABVENTURES

EntrackrEntrackr · 4h ago
ELMED Life Sciences raises $2.7 Mn in Series A from NABVENTURES
Medial

ELMED Life Sciences raises $2.7 Mn in Series A from NABVENTURES Biotech startup ELMED Life Sciences has raised $2.7 million (around Rs 25 crore) in a Series A funding round from AgriSURE Fund, managed by NABVENTURES. The proceeds will be used to expand manufacturing capacity, strengthen research and development, and scale its distribution across domestic and international markets. Founded by Pruthivin Reddy Madduri and co-founded by Nikhil Konkathi, ELMED Life Sciences develops probiotic and biological solutions across animal health, agriculture, aquaculture, and human health. The firm offers products for poultry, dairy, livestock, aquaculture, and soil health, focusing on improving productivity and sustainability through microbiome-based solutions. ELMED plans to expand its manufacturing operations in Hyderabad and deepen its distribution in tier 2 and tier 3 markets. It is also looking to strengthen its presence in international markets, where demand for antibiotic-free and sustainable solutions is increasing. The brand currently exports to over 18 countries and operates a B2B model serving enterprise clients across sectors.

1

Related News

Global HealthX crosses $15 Mn in healthcare investments, unveils startup cohort

EntrackrEntrackr · 1m ago
Global HealthX crosses $15 Mn in healthcare investments, unveils startup cohort
Medial

Global HealthX, the healthcare and life sciences innovation hub under the Global University Foundation, has crossed $15 million in investments across healthcare and life sciences startups, as well as studio-built ventures, over the past two years. Operating at the intersection of healthcare, life sciences, and technology, Global HealthX brings together a venture studio, strategic investments, and market-access partnerships within a single, integrated model. The platform aims to address structural gaps in India’s healthcare ecosystem, particularly in access, affordability, and continuity of care. The most recent cohort includes five startups — TapHealth, Wellytics, Monitra Health, Merry Health, and Avika — working across AI-led chronic care, cardiac monitoring, emergency response, genomics-driven precision medicine, and VR-based mental health therapy. The Hyderabad-based firm typically invests between $250,000 and $500,000 per company, with flexibility for follow-on investments from pre-seed to Series A and beyond, depending on scale and impact potential. Looking ahead, Global HealthX plans to deploy $8–10 million in 2026 across 10 additional startups spanning healthcare and life sciences, reinforcing its commitment to building long-term healthcare infrastructure in India while enabling the right market access. Led by Ravindranath Kancherla, Global HealthX (GHX) is a healthcare and life sciences venture studio, accelerator, and investment fund focused on innovation, R&D, and startup acceleration in India. Operating as the innovation arm of the Global Institute for Research & Innovation (GIRI), it aims to make healthcare more accessible through technology and expert mentorship.

JustDeliveries raises $1 Mn in pre-Series A round

EntrackrEntrackr · 1y ago
JustDeliveries raises $1 Mn in pre-Series A round
Medial

Logistics solutions for perishables JustDeliveries has raised $1 million in its pre-Series A round led by Nabventures. Faad Network, Anay Ventures, Caret Capital and Mahansaria Family Office have also participated in the round. The proceeds will be used to deepen its logistics network across regions including Bengaluru, Mumbai, Pune and the national capital region, the company said in a press release. It will also launch operations in Hyderabad. Within the next 3-4 years, JustDeliveries plans to extend its presence to 8-10 cities across India. Founded in 2022 by Mahansaria, JustDeliveries solves the challenges of fragmented cold supply chain for perishables and works with leading QSRs, café chains, and brands with fresh and frozen products. Nabventures, a subsidiary of the Indian government’s National Bank for Agriculture and Rural Development (Nabard) invests in agritech, foodtech, rural fintech, healthtech and edtech startups. Its other investments include Unnati, Jai Kisan and TenderCuts in the food and agricultural space.

Specialty chemicals startup Scimplify raises $40 Mn in Series B round

EntrackrEntrackr · 1y ago
Specialty chemicals startup Scimplify raises $40 Mn in Series B round
Medial

Scimplify, a platform for sourcing and manufacturing specialty chemicals, has raised $40 million in a Series B funding round co-led by Accel and Bertelsmann India Investments, with participation from UMI and existing investors, including Omnivore and 3one4 Capital. This funding brings Scimplify’s total capital raised to $54 million, following its seed and Series A rounds. The fresh capital will accelerate Scimplify’s export expansion beyond the 16 countries it currently serves while strengthening its presence in key industries such as life sciences, crop sciences, and industrial chemicals, the company said in a press release. Many manufacturers struggle with sourcing raw materials, navigating regulatory requirements, and scaling up production to meet global demand. Scimplify addresses these challenges by offering an end-to-end manufacturing ecosystem, combining in-house scientific expertise with a network of over 200 specialized manufacturing plants across cost-efficient regions in India. Founded by Salil Srivastava and Sachin Santhosh, Scimplify is a B2B fulfillment platform that operates across the product life cycle, from contract research to commercial chemical manufacturing, serving industries such as pharmaceuticals, personal care, and agrochemicals. The company’s plug-and-play model enables global buyers to leverage India’s cost-efficient production capabilities without the burden of setting up dedicated manufacturing facilities. “As global supply chains undergo rapid shifts, customers are actively seeking reliable partners who can provide enterprise-grade R&D and comprehensive solutions for their specialty chemical manufacturing needs. Over the past year and a half, we have built great momentum, and with Accel joining this partnership, we remain steadfast in building a global R&D-led manufacturing company that brings a new-age approach to the modern customer,” said Srivastava. The Bengaluru-based company serves major markets, including the US, Europe, and Japan. Scimplify competes with Mstack, Atomgrid, Covvalent, Distil, and Elchemy.

Download the medial app to read full posts, comements and news.